Score Overview
Explore the 2021 public Archive ranking โ
Where Geron Corporation has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- GERN
2007: 95.3% ยท 2021: 82.6% ยท free through 2021 ยท longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-11-17 | $ 1.00 | โ |
1 Year2025-11-17 | $ 1.13 | -11.50% |
5 Years2021-11-17 | $ 1.42 | -29.58% |
10 Years2016-11-17 | $ 2.19 | -54.34% |
20 Years2006-11-17 | $ 8.27 | -87.91% |
30 Years1996-11-15 | $ 6.44 | -84.47% |
| Period | Last Price2026-11-17 | 1 Year2025-11-17 | 5 Years2021-11-17 | 10 Years2016-11-17 | 20 Years2006-11-17 | 30 Years1996-11-15 |
|---|---|---|---|---|---|---|
| Price | $ 1.00 | $ 1.13 | $ 1.42 | $ 2.19 | $ 8.27 | $ 6.44 |
| Return | โ | -11.50% | -29.58% | -54.34% | -87.91% | -84.47% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 217M | -$ 50M | $ 288M |
| 2025 | $ 183M | -$ 85M | $ 359M |
| 2024 | $ 76M | -$ 174M | $ 406M |
| 2023 | -$ 184M | $ 333M | |
| 2022 | $ 596K | -$ 141M | $ 172M |
| 2021 | $ 1M | -$ 116M | $ 183M |
| 2020 | $ 253K | -$ 75M | $ 196M |
| 2019 | $ 460K | -$ 63M | $ 139M |
| 2018 | $ 1M | -$ 27M | $ 163M |
| 2017 | $ 1M | -$ 27M | $ 94M |
| 2016 | $ 6M | -$ 29M | $ 115M |
| 2015 | $ 36M | $ 114M | |
| 2014 | $ 1M | -$ 35M | $ 151M |
| 2013 | $ 1M | -$ 38M | $ 65M |
| 2012 | $ 2M | -$ 68M | $ 96M |
| 2011 | $ 2M | -$ 96M | $ 121M |
| 2010 | $ 3M | -$ 111M | $ 186M |
| 2009 | $ 1M | -$ 70M | $ 111M |
| 2008 | $ 2M | -$ 62M | $ 162M |
| 2007 | $ 7M | -$ 36M | $ 206M |
| 2006 | $ 3M | -$ 31M | $ 213M |
| 2005 | $ 290K | -$ 33M | $ 190M |
| 2004 | $ 1M | -$ 80M | $ 119M |
| 2003 | $ 1M | -$ 29M | $ 109M |
| 2002 | $ 1M | -$ 33M | $ 46M |
| 2001 | $ 3M | -$ 42M | $ 68M |
| 2000 | $ 6M | -$ 45M | $ 33M |
| 1999 | $ 5M | -$ 46M | $ 7M |
| 1998 | $ 6M | -$ 10M | $ 16M |
| 1997 | $ 7M | -$ 9M | $ 4M |
| IPO1996 | $ 5M | -$ 10M | $ 12M |

Geron Corporation fundamental performance
Between 2020 and 2025, revenue grew from $ 253K to $ 183M and net income went from -$ 75M to -$ 85M. Revenue increased in 3 of those 5 years; net income in 3.
Between 2015 and 2025, revenue grew from $ 36M to $ 183M. Revenue increased in 5 of those 10 years; net income in 5.
Geron Corporation currently holds a 20-year HDB Score of 3.0 out of 10. How the HDB Score is calculated.
Membership
Continue GERNโs history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,187 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
XTL Biopharmaceuticals Ltd ADRXTLBยท revenue grew in 69% of years
BioCryst Pharmaceuticals IncBCRXยท revenue grew in 55% of years
Teva Pharma Industries Ltd ADRTEVAยท revenue grew in 55% of years
Cytokinetics IncCYTKยท revenue grew in 70% of years
Arrowhead Pharmaceuticals IncARWRยท revenue grew in 50% of years